--- title: "China Resources Medical Holdings Company Limited (01515.HK)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/01515.HK.md" symbol: "01515.HK" name: "China Resources Medical Holdings Company Limited" industry: "Health Care Facilities" --- # China Resources Medical Holdings Company Limited (01515.HK) | Item | Detail | |------|--------| | Industry | Health Care Facilities | | Location | HK Market | | Website | [www.crmedical.hk](https://www.crmedical.hk) | ## Company Profile China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People’s Republic of China. It operates through two segments Hospital and Other Business. The Hospital segment offers out-pati... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-17T04:30:10.000Z **Overall: C (0.45)** **Industry**: Health Care Facilities | Metric | Value | |--------|-------| | Industry Ranking | 4 / 18 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -5.54% | | | Net Profit YoY | 60.62% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.57 | | | Dividend Ratio | 4.62% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 4.03B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 10.19B | | **Multi Score**: C #### Profit Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 7.47% | B | | Profit Margin | 5.01% | C | | Gross Margin | 15.75% | D | #### Growth Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -5.54% | D | | Net Profit YoY | 60.62% | B | | Total Assets YoY | 0.87% | C | | Net Assets YoY | 6.23% | B | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 1994.55% | A | | OCF YoY | -5.54% | D | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.69 | B | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 42.82% | C | ```chart-data:radar { "title": "Longbridge Financial Score - China Resources Medical Holdings Company Limited", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "C", "indicators": [ { "name": "ROE", "value": "7.47%", "rating": "B" }, { "name": "Profit Margin", "value": "5.01%", "rating": "C" }, { "name": "Gross Margin", "value": "15.75%", "rating": "D" } ] }, { "name": "Growth", "grade": "C", "indicators": [ { "name": "Revenue YoY", "value": "-5.54%", "rating": "D" }, { "name": "Net Profit YoY", "value": "60.62%", "rating": "B" }, { "name": "Total Assets YoY", "value": "0.87%", "rating": "C" }, { "name": "Net Assets YoY", "value": "6.23%", "rating": "B" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "1994.55%", "rating": "A" }, { "name": "OCF YoY", "value": "-5.54%", "rating": "D" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.69", "rating": "B" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "42.82%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | SAINT BELLA (HK.2508) | D | A | B | B | B | B | | 02 | HYGEIA HEALTH (HK.6078) | C | D | C | B | C | C | | 03 | BAYZED HEALTH (HK.2609) | D | C | C | B | D | C | | 04 | CR MEDICAL (HK.1515) | C | C | B | C | C | C | | 05 | CHAOJU EYE CARE (HK.2219) | B | D | C | A | C | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 7.80 | 3/19 | 8.93 | 8.48 | 8.05 | | PB | 0.57 | 5/19 | 0.79 | 0.68 | 0.61 | | PS (TTM) | 0.39 | 4/19 | 0.49 | 0.45 | 0.42 | | Dividend Yield | 4.62% | 4/19 | 4.33% | 3.80% | 3.19% | ## Institutional View ### Analyst Rating Distribution > As of 2025-12-24T16:00:00.000Z Total Analysts: **3** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 33% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 2 | 67% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 3.11 | | Highest Target | 5.07 | | Lowest Target | 3.00 | ## References - [Company Overview](https://longbridge.com/en/quote/01515.HK/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/01515.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/01515.HK/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.